These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Investigational small molecules in phase II clinical trials for the treatment of epilepsy. Greco M; Varriale G; Coppola G; Operto F; Verrotti A; Iezzi ML Expert Opin Investig Drugs; 2018 Dec; 27(12):971-979. PubMed ID: 30408428 [TBL] [Abstract][Full Text] [Related]
26. AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel. Zaccara G; Giovannelli F; Cincotta M; Iudice A Expert Rev Neurother; 2013 Jun; 13(6):647-55. PubMed ID: 23739002 [TBL] [Abstract][Full Text] [Related]
27. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures. Gidal BE; Ferry J; Majid O; Hussein Z Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853 [TBL] [Abstract][Full Text] [Related]
29. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Tassone DM; Boyce E; Guyer J; Nuzum D Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045 [TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapy for children and adolescents with epilepsy. Verrotti A; Loiacono G; Coppola G; Spalice A; Mohn A; Chiarelli F Expert Opin Pharmacother; 2011 Feb; 12(2):175-94. PubMed ID: 21208135 [TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy. Vera-Llonch M; Brandenburg NA; Oster G Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431 [TBL] [Abstract][Full Text] [Related]
32. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials. Uthman BM; Almas M; Emir B; Giordano S; Leon T Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392 [TBL] [Abstract][Full Text] [Related]